NASDAQ:PBYI - Puma Biotechnology Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$42.17 +3.00 (+7.66 %)
(As of 03/18/2019 02:38 PM ET)
Previous Close$39.17
Today's Range$40.11 - $43.82
52-Week Range$17.60 - $75.29
Volume49,942 shs
Average Volume1.18 million shs
Market Capitalization$1.62 billion
P/E Ratio-14.34
Dividend YieldN/A
Beta0.64

Analyst Ratings

Puma Biotechnology (NASDAQ:PBYI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
12 Wall Street analysts have issued ratings and price targets for Puma Biotechnology in the last 12 months. Their average twelve-month price target is $52.20, suggesting that the stock has a possible upside of 23.78%. The high price target for PBYI is $106.00 and the low price target for PBYI is $21.00. There are currently 3 sell ratings, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.082.082.182.55
Ratings Breakdown: 3 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $52.20$59.70$69.10$97.10
Price Target Upside: 23.78% upside135.69% upside207.11% upside107.70% upside

Puma Biotechnology (NASDAQ:PBYI) Consensus Price Target History

Price Target History for Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/3/2019JPMorgan Chase & Co.Reiterated RatingSell$27.00MediumView Rating Details
3/1/2019CowenReiterated RatingHold$68.00LowView Rating Details
3/1/2019CitigroupBoost Price TargetBuy ➝ Buy$67.00 ➝ $70.00MediumView Rating Details
2/28/2019Cantor FitzgeraldReiterated RatingBuy$57.00HighView Rating Details
1/17/2019Leerink SwannInitiated CoverageMkt Perform ➝ Market Perform$21.00LowView Rating Details
1/3/2019GuggenheimDowngradeBuy ➝ NeutralHighView Rating Details
12/18/2018Royal Bank of CanadaBoost Price TargetPositive ➝ Sector Perform$29.00LowView Rating Details
11/19/2018Goldman Sachs GroupUpgradeSell ➝ Neutral$36.00 ➝ $28.00MediumView Rating Details
11/2/2018Bank of AmericaDowngradeBuy ➝ UnderperformHighView Rating Details
11/2/2018BarclaysDowngradeEqual Weight ➝ Underweight$72.00 ➝ $29.00HighView Rating Details
5/11/2018Stifel NicolausLower Price TargetBuy ➝ Buy$95.00 ➝ $87.00MediumView Rating Details
5/7/2018Credit Suisse GroupSet Price TargetBuy$106.00MediumView Rating Details
(Data available from 3/18/2017 forward)
This page was last updated on 3/18/2019 by MarketBeat.com Staff

Featured Article: Capital Gains

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel